1488000
USP
羟吗啡酮标准液
United States Pharmacopeia (USP) Reference Standard
别名:
4,5α-Epoxy-3,14-dihydroxy-17-methylmorphinan-6-one, Dihydroxymorphinone
等级
pharmaceutical primary standard
API类
oxymorphone
制造商/商品名称
USP
药品控制
USDEA Schedule I; regulated under CDSA - not available from Sigma-Aldrich Canada; estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal); Kábítószer / Narcotic Drug (Hungary), 78/2022. (XII. 28.) BM rendelet
应用
pharmaceutical (small molecule)
包装形式
neat
SMILES字符串
N1([C@H]2[C@]3([C@@]4([C@@H](Oc5c4c(ccc5O)C2)C(=O)CC3)CC1)O)C
InChI
1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1
InChI key
UQCNKQCJZOAFTQ-ISWURRPUSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
For further information and support please go to the website of the issuing Pharmacopoeia.
应用
- Oxymorphone Hydrochloride
- Oxymorphone Hydrochloride Extended-Release Tablets
- Oxymorphone Hydrochloride Injection
- Oxymorphone Hydrochloride Tablets
分析说明
其他说明
警示用语:
Warning
危险声明
预防措施声明
危险分类
Acute Tox. 4 Oral - STOT SE 3
靶器官
Central nervous system
储存分类代码
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持